{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:53:33Z","timestamp":1761630813329,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":1727,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1111\/ajt.14664","type":"journal-article","created":{"date-parts":[[2018,1,15]],"date-time":"2018-01-15T23:36:39Z","timestamp":1516059399000},"page":"767-768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comments on Famulski and Halloran AJT i-IFTA letter"],"prefix":"10.1016","volume":"18","author":[{"given":"Michael","family":"Mengel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.14664_bib1","doi-asserted-by":"crossref","unstructured":"Famulski KS, Halloran PF. Letter to AJT editor re: Nankivell et al [published online ahead of print January 9, 2018]. Am J Transplant. https:\/\/doi.org\/10.1111\/ajt.14653","DOI":"10.1111\/ajt.14653"},{"key":"10.1111\/ajt.14664_bib2","doi-asserted-by":"crossref","unstructured":"Haas M, Loupy A, Lefaucheur C, et al. The Banff kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials [published online ahead of print 2017]. Am J Transplant. https:\/\/doi.org\/10.1111\/ajt.14625","DOI":"10.1111\/ajt.14625"},{"issue":"9","key":"10.1111\/ajt.14664_bib3","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/j.1600-6143.2010.03240.x","article-title":"Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure","volume":"10","author":"Mannon","year":"2010","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.14664_bib4","doi-asserted-by":"crossref","unstructured":"Nankivell B, Shingde M, Keung K, et al. The causes, significance, and consequences of inflammatory fibrosis in kidney transplantation: the Banff i-IFTA lesion [published online ahead of print 2017]. Am J Transplant. https:\/\/doi.org\/10.1111\/ajt.14609.","DOI":"10.1111\/ajt.14609"},{"key":"10.1111\/ajt.14664_bib5","doi-asserted-by":"crossref","unstructured":"Lefaucheur C, Gosset C, Rabant M, et al. T cell-mediated rejection as a major determinant of inflammation in scarred areas in kidney transplant recipients [published online ahead of print 2017]. Am J Transplant. https:\/\/doi.org\/10.1111\/ajt.14565.","DOI":"10.1111\/ajt.14565"},{"key":"10.1111\/ajt.14664_bib6","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1111\/ajt.14329","article-title":"Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX study","volume":"17","author":"Halloran","year":"2017","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.14664_bib7","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1681\/ASN.V1081806","article-title":"The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies","volume":"10","author":"Meehan","year":"1999","journal-title":"J Am Soc Nephrol."},{"key":"10.1111\/ajt.14664_bib8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1600-6143.2010.03415.x","article-title":"Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases","volume":"11","author":"Sellares","year":"2011","journal-title":"Am J Transplant."},{"key":"10.1111\/ajt.14664_bib9","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant."},{"issue":"12","key":"10.1111\/ajt.14664_bib10","doi-asserted-by":"crossref","first-page":"94197","DOI":"10.1172\/jci.insight.94197","article-title":"Assessing rejection-related in kidney transplant biopsies based on archetypal analysis of molecular phenotypes","volume":"2","author":"Reeve","year":"2017","journal-title":"JCI Insight"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14664","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522094783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522094783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.14664\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:20:42Z","timestamp":1761628842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522094783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1600613522094783"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14664","relation":{},"ISSN":["1600-6135"],"issn-type":[{"type":"print","value":"1600-6135"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comments on Famulski and Halloran AJT i-IFTA letter","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}